|
Update on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer |
|
|
|
Titel: |
Update on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer |
Auteur: |
Smyth, L.M. Saura, C. Piha-Paul, S.A. Lu, J. Mayer, I.A. Brufksy, A.M. Spanggaard, I. Arnedos, M. Cutler, R.E. Hyman, D.M. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 30 () nr. S3 pagina's iii10-iii11 |
Jaar: |
2019 |
Inhoud: |
|
Uitgever: |
THE AUTHORS |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|